These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26468097)

  • 21. (Z)-4-bromo-5-(bromomethylene)-3-methylfuran-2(5H)-one sensitizes Escherichia coli persister cells to antibiotics.
    Pan J; Xie X; Tian W; Bahar AA; Lin N; Song F; An J; Ren D
    Appl Microbiol Biotechnol; 2013 Oct; 97(20):9145-54. PubMed ID: 24006079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disrupting folate metabolism reduces the capacity of bacteria in exponential growth to develop persisters to antibiotics.
    Morgan J; Smith M; Mc Auley MT; Enrique Salcedo-Sora J
    Microbiology (Reading); 2018 Nov; 164(11):1432-1445. PubMed ID: 30247120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigating the Effects of Osmolytes and Environmental pH on Bacterial Persisters.
    Karki P; Mohiuddin SG; Kavousi P; Orman MA
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32094133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persister cells mediate tolerance to metal oxyanions in Escherichia coli.
    Harrison JJ; Ceri H; Roper NJ; Badry EA; Sproule KM; Turner RJ
    Microbiology (Reading); 2005 Oct; 151(Pt 10):3181-3195. PubMed ID: 16207903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Escherichia coli persister cells suppress translation by selectively disassembling and degrading their ribosomes.
    Cho J; Rogers J; Kearns M; Leslie M; Hartson SD; Wilson KS
    Mol Microbiol; 2015 Jan; 95(2):352-64. PubMed ID: 25425348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bacterial persisters tolerate antibiotics by not producing hydroxyl radicals.
    Kim JS; Heo P; Yang TJ; Lee KS; Jin YS; Kim SK; Shin D; Kweon DH
    Biochem Biophys Res Commun; 2011 Sep; 413(1):105-10. PubMed ID: 21872573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analyzing Persister Physiology with Fluorescence-Activated Cell Sorting.
    Orman MA; Henry TC; DeCoste CJ; Brynildsen MP
    Methods Mol Biol; 2016; 1333():83-100. PubMed ID: 26468102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emergence of fluoroquinolone resistance in Escherichia coli isolates at the department of clinical hematology.
    Zemkova M; Kotlarova J; Merka V; Cermak P; Vlcek J; Jebavy L
    New Microbiol; 2007 Oct; 30(4):423-30. PubMed ID: 18080678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Establishment of a method to rapidly assay bacterial persister metabolism.
    Orman MA; Brynildsen MP
    Antimicrob Agents Chemother; 2013 Sep; 57(9):4398-409. PubMed ID: 23817376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid and sensitive detection of fluoroquinolone-resistant Escherichia coli from urine samples using a genotyping DNA microarray.
    Yu X; Susa M; Weile J; Knabbe C; Schmid RD; Bachmann TT
    Int J Med Microbiol; 2007 Oct; 297(6):417-29. PubMed ID: 17482874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Persister cells.
    Lewis K
    Annu Rev Microbiol; 2010; 64():357-72. PubMed ID: 20528688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contribution of a new mutation in parE to quinolone resistance in extended-spectrum-beta-lactamase-producing Escherichia coli isolates.
    Sorlozano A; Gutierrez J; Jimenez A; de Dios Luna J; Martínez JL
    J Clin Microbiol; 2007 Aug; 45(8):2740-2. PubMed ID: 17567787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Birth and Resuscitation of (p)ppGpp Induced Antibiotic Tolerant Persister Cells.
    Svenningsen MS; Veress A; Harms A; Mitarai N; Semsey S
    Sci Rep; 2019 Apr; 9(1):6056. PubMed ID: 30988388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High diversity and abundance of antibiotic-resistant Escherichia coli isolated from humans and farm animal hosts in Jeonnam Province, South Korea.
    Unno T; Han D; Jang J; Lee SN; Kim JH; Ko G; Kim BG; Ahn JH; Kanaly RA; Sadowsky MJ; Hur HG
    Sci Total Environ; 2010 Aug; 408(17):3499-506. PubMed ID: 20510439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genome-wide transcriptome analysis of fluoroquinolone resistance in clinical isolates of Escherichia coli.
    Yamane T; Enokida H; Hayami H; Kawahara M; Nakagawa M
    Int J Urol; 2012 Apr; 19(4):360-8. PubMed ID: 22211478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Uninhibited antibiotic target discovery via chemical genetics.
    Poole K
    Nat Biotechnol; 2004 Dec; 22(12):1528-9. PubMed ID: 15583660
    [No Abstract]   [Full Text] [Related]  

  • 37. Protocol for assessing single-cell persister recovery kinetics and physiology in Escherichia coli using spectrophotometry.
    Nguyen SD; Verstraeten N; Michiels J
    STAR Protoc; 2024 Jun; 5(2):102984. PubMed ID: 38592975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extraintestinal pathogenic Escherichia coli: an update on antimicrobial resistance, laboratory diagnosis and treatment.
    Pitout JD
    Expert Rev Anti Infect Ther; 2012 Oct; 10(10):1165-76. PubMed ID: 23199402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotypic tolerance: antibiotic enrichment of noninherited resistance in bacterial populations.
    Wiuff C; Zappala RM; Regoes RR; Garner KN; Baquero F; Levin BR
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1483-94. PubMed ID: 15793130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medium chain unsaturated fatty acid ethyl esters inhibit persister formation of Escherichia coli via antitoxin HipB.
    Wang M; Fang K; Hong SMC; Kim I; Jang IS; Hong SH
    Appl Microbiol Biotechnol; 2018 Oct; 102(19):8511-8524. PubMed ID: 30088019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.